Continuous Acoramidis Treatment Significantly Reduced Risk Of All-cause Mortality And Cardiovascular-related Hospitalization At Month 42, In Patients With Wild-type And Variant Transthyretin Amyloidosis Cardiomyopathy

Martha Grogan, Amrut Ambardekar, Justin Grodin, Lily Stern, Prem Soman, Marianna Fontana, Pablo Garcia-Pavia, Kuangnan Xiong, Suresh Siddhanti, Jean-François Tamby, Jonathan C. Fox, Nowell Fine, Mathew Maurer

Click the link below to download a PDF copy of this oral presentation.

Poster download

Click the link below to download a PDF copy of the Plain Language Summary.

Click the link below to listen to the audio recording.

Grogan M, et al. Presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting, September 26 - 29, 2025, Minneapolis, MN